Montag & Associates’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $441K | Hold |
2,611
| – | – | 0.02% | 322 |
|
|
2025
Q4 | $441K | Sell |
2,611
-175
| -6% | -$28.4K | 0.02% | 313 |
|
|
2025
Q3 | $402K | Hold |
2,786
| – | – | 0.02% | 328 |
|
|
2025
Q2 | $352K | Buy |
2,786
+11
| +0.4% | +$1.35K | 0.02% | 336 |
|
|
2025
Q1 | $355K | Hold |
2,775
| – | – | 0.02% | 342 |
|
|
2024
Q4 | $367K | Hold |
2,775
| – | – | 0.02% | 342 |
|
|
2024
Q3 | $404K | Sell |
2,775
-45
| -2% | -$6.51K | 0.02% | 346 |
|
|
2024
Q2 | $387K | Hold |
2,820
| – | – | 0.02% | 337 |
|
|
2024
Q1 | $387K | Hold |
2,820
| – | – | 0.02% | 347 |
|
|
2023
Q4 | $383K | Buy |
2,820
+175
| +7% | +$21.4K | 0.02% | 329 |
|
|
2023
Q3 | $324K | Hold |
2,645
| – | – | 0.02% | 330 |
|
|
2023
Q2 | $336K | Hold |
2,645
| – | – | 0.02% | 335 |
|
|
2023
Q1 | $342K | Hold |
2,645
| – | – | 0.02% | 323 |
|
|
2022
Q4 | $347K | Hold |
2,645
| – | – | 0.02% | 308 |
|
|
2022
Q3 | $309K | Buy |
2,645
+750
| +40% | +$93.1K | 0.02% | 313 |
|
|
2022
Q2 | $223K | Sell |
1,895
-200
| -10% | -$23.7K | 0.01% | 350 |
|
|
2022
Q1 | $273K | Hold |
2,095
| – | – | 0.01% | 355 |
|
|
2021
Q4 | $320K | Sell |
2,095
-459
| -18% | -$71.1K | 0.02% | 340 |
|
|
2021
Q3 | $413K | Hold |
2,554
| – | – | 0.02% | 310 |
|
|
2021
Q2 | $418K | Hold |
2,554
| – | – | 0.02% | 308 |
|
|
2021
Q1 | $385K | Hold |
2,554
| – | – | 0.02% | 313 |
|
|
2020
Q4 | $387K | Buy |
2,554
+45
| +2% | +$6.43K | 0.02% | 292 |
|
|
2020
Q3 | $340K | Hold |
2,509
| – | – | 0.03% | 257 |
|
|
2020
Q2 | $343K | Hold |
2,509
| – | – | 0.03% | 247 |
|
|
2020
Q1 | $270K | Buy |
2,509
+459
| +22% | +$52.8K | 0.03% | 252 |
|
|
2019
Q4 | $247K | Sell |
2,050
-90
| -4% | -$10K | 0.02% | 277 |
|
|
2019
Q3 | $213K | Hold |
2,140
| – | – | 0.02% | 287 |
|
|
2019
Q2 | $233K | Hold |
2,140
| – | – | 0.02% | 284 |
|
|
2019
Q1 | $239K | Hold |
2,140
| – | – | 0.02% | 281 |
|
|
2018
Q4 | $206K | Sell |
2,140
-22,375
| -91% | -$2.37M | 0.02% | 274 |
|
|
2018
Q3 | $2.99M | Buy |
+24,515
| New | +$2.89M | 0.26% | 92 |
|
|
2018
Q1 | – | Sell |
-19,155
| Closed | -$2.04M | – | 291 |
|
|
2017
Q4 | $2.04M | Sell |
19,155
-1,050
| -5% | -$112K | 0.2% | 128 |
|
|
2017
Q3 | $2.25M | Buy |
+20,205
| New | +$2.16M | 0.24% | 109 |
|
Other funds holding IBB
CB
Montag & Associates's IBB Position: Q1 2026 in Review
Montag & Associates held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 2,611 shares worth $441K. The position accounts for 0.02% of the portfolio, ranked #322.
Montag & Associates first reported a position in IBB in Q3 2017 and has held it in 33 quarters since. The position peaked at $2.99M in Q3 2018. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Montag & Associates held 2,611 shares of iShares Biotechnology ETF worth $441K as of Q1 2026.
- Montag & Associates left its iShares Biotechnology ETF share count unchanged in Q1 2026.
- iShares Biotechnology ETF made up 0.02% of Montag & Associates's portfolio in Q1 2026, its #322 holding.
- Montag & Associates first reported a position in iShares Biotechnology ETF in Q3 2017 and has held it in 33 quarters since.
- Montag & Associates's iShares Biotechnology ETF position peaked at $2.99M in Q3 2018.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.